Dashboard
Manage Tickers

PODD INSULET CORP

Nasdaq insulet.com


$ 318.59 $ 2.30 (0.73 %)    

Friday, 17-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 318.59
$ 315.40
$ 306.05 x 30
$ 325.00 x 50
$ 315.17 - $ 321.63
$ 226.50 - $ 353.50
376,883
na
22.43B
$ 1.14
$ 94.99
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-24-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-07-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 04-29-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

price-over-earnings-overview-insulet
Price Over Earnings Overview: Insulet
09/30/2025 18:00:26

heres-how-much-100-invested-in-insulet-15-years-ago-would-be-worth-today
Here's How Much $100 Invested In Insulet 1...
09/29/2025 21:44:22

Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average...

a-glimpse-into-the-expert-outlook-on-insulet-through-6-analysts
A Glimpse Into The Expert Outlook On Insul...
09/29/2025 12:02:55

6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish ...

canaccord-genuity-maintains-buy-on-insulet-raises-price-target-to-399
Canaccord Genuity Maintains Buy on Insulet...
09/29/2025 11:55:35

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ: PODD) with a Buy and raises the price target from $353...

heres-how-much-100-invested-in-insulet-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Insulet 1...
09/19/2025 23:30:26

tech-stocks-slip-small-caps-soar-ahead-of-fed-rate-decision-whats-moving-markets-wednesday
Tech Stocks Slip, Small Caps Soar Ahead Of...
09/17/2025 16:44:27

Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&am...

insulet-appoints-flavia-pease-as-new-cfo-ana-maria-chadwick-transitions-to-senior-advisor-role-expects-to-beat-q3-revenue-guidance
Insulet Appoints Flavia Pease As New CFO, ...
09/16/2025 11:06:51

Insulet Corporation (NASDAQ:PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump tech...

assessing-insulet-insights-from-6-financial-analysts
Assessing Insulet: Insights From 6 Financi...
09/08/2025 20:01:26

oppenheimer-maintains-outperform-on-insulet-raises-price-target-to-365
Oppenheimer Maintains Outperform on Insule...
09/08/2025 14:37:41

Oppenheimer analyst Steven Lichtman maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $324 ...

100-invested-in-this-stock-15-years-ago-would-be-worth-this-much-today
$100 Invested In This Stock 15 Years Ago W...
09/03/2025 14:00:34

insulet-appoints-eric-benjamin-as-chief-operating-officer-effective-immediately
Insulet Appoints Eric Benjamin As Chief Op...
08/25/2025 21:02:37

demystifying-insulet-insights-from-7-analyst-reviews
Demystifying Insulet: Insights From 7 Anal...
08/21/2025 18:01:22

barclays-maintains-equal-weight-on-insulet-raises-price-target-to-300
Barclays Maintains Equal-Weight on Insulet...
08/21/2025 14:43:37

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $266 to $300.

cisco-rocket-companies-insulet-and-more-on-cnbcs-final-trades
Cisco, Rocket Companies, Insulet And More ...
08/20/2025 12:23:14

Lending support to his choice, BTIG analyst initiated coverage on Rocket Companies with a Buy rating and $25 price target. Cisc...

Core News & Articles
CNBC Halftime Report Final Trades: Rocket ...
08/19/2025 17:01:36

heres-how-much-you-would-have-made-owning-insulet-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
08/18/2025 14:45:24

is-the-market-bullish-or-bearish-on-insulet
Is the Market Bullish or Bearish on Insulet?
08/13/2025 18:00:37

canaccord-genuity-maintains-buy-on-insulet-raises-price-target-to-353
Canaccord Genuity Maintains Buy on Insulet...
08/08/2025 21:34:54

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $331 ...

rbc-capital-maintains-outperform-on-insulet-raises-price-target-to-350
RBC Capital Maintains Outperform on Insule...
08/08/2025 18:03:52

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $330 to ...

wells-fargo-maintains-overweight-on-insulet-raises-price-target-to-350
Wells Fargo Maintains Overweight on Insule...
08/08/2025 15:08:11

Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $3...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION